Perineural Therapy Market Share

  • Report ID: 4161
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Perineural Therapy Market Share

North American Market Forecast

North America industry is likely to account for largest revenue share by 2037. The market is projected to witness remarkable growth on the back of a higher prevalence of sports injuries. Approximately 30 million teens participate in organized sports, out of which, around 3.5 million get injured annually. Hence, the market is expected to grow exponentially in the region over the forecast period. Also, a lot of technological advancements have taken place in perineural therapy which is expected to drive the market in this region. Nerve grafting and neuropathy are becoming more prominent in this region, which raising the market share in North America.

APAC Market Statistics

Furthermore, the Asia Pacific region is estimated to be the second-largest shareholder in the global perineural therapy market. The growth of the market in the region can be attributed to the skyrocketing cases of Alzheimer’s disease, dementia, and other chronic disorders. For instance, the number of people with dementia is projected to reach around 70 million by the year 2050 in the Asia Pacific region. Additionally, the rising geriatric population with severed nerves is further estimated to drive the growth of the market over the forecast period. As per the data provided by the Asian Development Bank, the elderly population in Asia Pacific is slated to reach around 923 million by the year 2050. Thereby, all these factors are expected to hike the growth of the market during the forecast period.

Research Nester
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4161
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of perineural therapy is assessed at USD 502.87 million.

The perineural therapy market size was valued at USD 399.17 million in 2024 and is expected to reach USD 2.54 billion by 2037, registering around 15.3% CAGR during the forecast period i.e., between 2025-2037. The higher prevalence of different sorts of neural disorders and the increment in approval of more enhanced products to repair and regenerate nerves will boost the market growth.

North America industry is likely to account for largest revenue share by 2037, on the back of a higher prevalence of sports injuries.

The major players in the market are Boston Scientific Corporation, tVNS Technologies GmbH, Abbott Laboratories, NeuroSigma, Inc., Axogen Corporation, BioWave Limited, Baxter Healthcare Corporation, LivaNova, PLC, Integra LifeSciences Corporation, Soterix Medical, Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample